Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Iron Mountain

Kinder Morgan

ONEOK

Williams

Exxon Mobil

Investors love dividend stocks because they not only provide dependable income but also give investors a great opportunity for solid total return.

The 6 Highest Yielding S&P 500 Dividend Stocks Are Outstanding Buys Now

AstraZeneca

British American Tobacco

Walmart

With markets jittery due to a potential crisis in China, here are four low beta stocks to buy for portfolio protection and dividends. The post 4 Stocks to Buy for Protection From an Evergrande-Driven Correction appeared first on InvestorPlace.

4 Stocks to Buy for Protection From an Evergrande-Driven Correction

Gaming and Leisure Properties

Lumen Technologies

AT&T

These seven dividend stocks, all yielding 5% or more, make great additions to any income investor's portfolio. The post 7 High-Yield Dividend Stocks That Will Please Any Income Lover appeared first on InvestorPlace.

7 High-Yield Dividend Stocks That Will Please Any Income Lover

Black Hills

Federal Realty Investment Trust

Lowe's

National Fuel Gas

Philip Morris

ALPS Active REIT ETF

I found it interesting that there's not an index yet for the 32 "kings." We all know how hard it takes to create a royal mousetrap of repeatability. So 50 consecutive years of consistently increasing dividends is a very big deal.

Retire Rich With Royalty: 3 Dividend Kings On Sale

Altria (MO) closed at $48.03 in the latest trading session, marking a -0.23% move from the prior day.

Altria (MO) Dips More Than Broader Markets: What You Should Know

Altria Group, Inc. (NYSE: MO) shares have weakened from their recent highs above $50 even though the company announced its decision to increase the dividend by 4.7% to $0.90/quarterly share dividend. Fundamental analysis: Altria Group lifted its dividend by 4.7% Altria Group is an American corporation and one of the world's largest producers and marketers […] The post Altria Group lifted its dividend by 4.7%.

Altria Group lifted its dividend by 4.7%. Should I invest?

AGNC Investment

Enterprise Products Partners

Annaly Capital

With yields ranging from 7.4% to 10.2%, these ultra-high-yield stocks can pad investors' pocketbooks.

Got $100,000? These Dividend Stocks Can Collectively Net You Almost $8,700 in Annual Income

Hershey

PepsiCo

The consumer staples sector is very popular among dividend growth investors because these companies often have fairly recession proof business models. Due to this, consumer staples are often profitable through all stages of the economic cycle, allowing them to return capital to shareholders in the form of dividends.

3 Highly Profitable Consumer Staple Names to Buy for Income

Baxter

Colgate-Palmolive

Con Ed

Hormel Foods

Kellogg

Novartis

Northwest Natural Gas

Pinnacle West Capital

Reckitt Benckiser Group PLC

Unilever

Verizon

The market is 30% overvalued, and September is historically a time when many corrections begin. Fortunately, there are plenty of high-yield/low volatility blue chips to choose from.

14 High-Yield Blue Chips For A Rich Retirement

Dow Inc

Big yields might translate into big problems.

Danger Lurks for These 3 High-Yield Dividend Stocks

My last article focused on the near-term risk and return prospects of Altria Group and the thesis was it presents a perfect setup for a long call play.

Altria Group: A 11% Yield Bond With Coupon Growth In Disguise

AbbVie

SPDR Portfolio S&P 500 High Dividend ETF

Western Union

There are 80 companies in the S&P 500 High Dividend Index ETF. Here are seven dividend stocks to buy from this exchange-traded fund that yield at least 4%.

7 S&P 500 Dividend Stocks To Buy Yielding 4%

Enbridge

Omega Healthcare Investors

Some companies pay big-time dividends for holding their stock. These three will pay you 6% or more.

3 Stocks to Buy With Dividends Yielding More Than 6%

Vaping stocks are doing stock hot on Thursday as the U.S. Food and Drug Administration prepares to weigh in on e-cigarettes. The post Vaping Stocks: BTI, MO and PM Slip Ahead of FDA E-Cigarette Decisions appeared first on InvestorPlace.

Vaping Stocks: BTI, MO and PM Slip Ahead of FDA E-Cigarette Decisions

Turning Point Brands

The Food and Drug Administration (FDA) is expected to make a critical ruling on vaping on Thursday that could potentially create some extreme volatility among tobacco and cannabis stocks. FDA Ruling Imminent: The FDA is expected to issue new rules restricting or completely banning millions of e-cigarette products.

Tobacco Stocks Volatile Ahead Of Key FDA Vaping Ban Decision

Bristol-Myers

Lockheed Martin

LyondellBasell Industries

Merck

Star Bulk Carriers

Teekay LNG Partners

ViacomCBS

The portfolio is listed showing available M* fair values, 2021 dividend, dividend yield, and other metrics to reveal a list of 12 finalists and 9 winner buy candidates. Portfolio value up ~0.7% and 16.8% YTD with dividend yield stable @ 4.19%.

Rose 93 Stock Portfolio August Update, Morning Star Fair Values And Buy Candidate List

Energy Transfer LP Unit

Goldman Sachs BDC

Medical Properties Trust

PIMCO Corporate & Income Opportunity Fund

Southern Company

Starwood Property

After 27 weeks and $2,700, the Dividend Harvesting Portfolio is generating $184.67 in estimated annual income and $15.39 in monthly estimated income. In week 27 I added to Goldman Sachs BDC (GSBD), British American Tobacco (BTI), PIMCO Corporate & Income Opportunity Fund (PTY), and Kinder Morgan (KMI).

Dividend Harvesting: Week 27 Update, $2,700 Invested, $184.67 In Annual Dividends Yielding 6.73% With 46 Positions

Clorox

Sturm, Ruger & Company

These three companies are contrarian stocks that could pay off big for patient investors.

News for Altria Stock (MO)